Olema Pharmaceuticals, Inc.
OLMA
$4.42
$0.163.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -33.95% | -27.71% | -12.69% | 9.73% | 7.76% |
| Total Depreciation and Amortization | 4.24% | -5.44% | -6.98% | -2.14% | 5.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.46% | -15.46% | -25.45% | -34.42% | -32.07% |
| Change in Net Operating Assets | 1,655.86% | 375.81% | 2,720.48% | -96.45% | -119.49% |
| Cash from Operations | -24.63% | -13.63% | -15.04% | -2.70% | -2.03% |
| Capital Expenditure | -- | 8.09% | 49.04% | 54.05% | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,819.16% | -123.16% | -191.98% | -160.06% | -105.30% |
| Cash from Investing | -1,827.97% | -123.63% | -192.47% | -160.39% | -105.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 106.49% | -81.28% | 5,794.93% | 21,345.40% | 27,928.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 130.83% | -- | -- | -- |
| Cash from Financing | 101.49% | -81.20% | 5,788.64% | 21,320.21% | 27,928.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.22% | -189.97% | -273.18% | -137.09% | 353.36% |